Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucosidase inhibitors for treatment of HIV-1 infection.

AIDS research and human retroviruses - 1 Feb 1992

Ratner L

Abstract excerpt

The HIV-1 envelope protein is a glycoprotein composed of 120 kD and 41 kD subunits. It contains 30-38 potential asparagine-linked glycosylation sites which have been shown to play a role in CD4 binding, virus uptake, and cytopathogenicity. Several inhibitors of oligosaccharide attachment or modification have been tested. An agent which inhibits glucosidases, N-butyl deoxynojirimycin was found to inhibit HIV-1 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation
Share to Acquired Immunodeficiency Syndrome
Share to Amino Acid Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to Molecular Sequence Data

Share to Mutation

Share to Protein Processing, Post-Translational

Source

Identifiers

PMID: 1540404
DOI: 10.1089/aid.1992.8.165

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucosidase inhibitors for treatment of HIV-1 infection.PMID 1540404Read ↗

Recent strategies targeting HIV glycans in vaccine designSemantic proximity Read ↗

Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV.Semantic proximity Read ↗

The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry.Semantic proximity Read ↗

Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase InhibitorsSemantic proximity Read ↗

An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.Semantic proximity Read ↗

An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface.Semantic proximity Read ↗

Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.Semantic proximity Read ↗

Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes.Semantic proximity Read ↗

New Small-Molecule Inhibitor Class Targeting Human Immunodeficiency Virus Type 1 Virion MaturationSemantic proximity Read ↗

Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 InfectionSemantic proximity Read ↗

Galactonojirimycin derivatives restore mutant human beta-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse.Semantic proximity Read ↗

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.